218 related articles for article (PubMed ID: 26079411)
1. The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B.
Lao PJ; Betthauser TJ; Hillmer AT; Price JC; Klunk WE; Mihaila I; Higgins AT; Bulova PD; Hartley SL; Hardison R; Tumuluru RV; Murali D; Mathis CA; Cohen AD; Barnhart TE; Devenny DA; Mailick MR; Johnson SC; Handen BL; Christian BT
Alzheimers Dement; 2016 Apr; 12(4):380-90. PubMed ID: 26079411
[TBL] [Abstract][Full Text] [Related]
2. Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B.
Handen BL; Cohen AD; Channamalappa U; Bulova P; Cannon SA; Cohen WI; Mathis CA; Price JC; Klunk WE
Alzheimers Dement; 2012 Nov; 8(6):496-501. PubMed ID: 23102120
[TBL] [Abstract][Full Text] [Related]
3. Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.
Oh H; Madison C; Baker S; Rabinovici G; Jagust W
Brain; 2016 Aug; 139(Pt 8):2275-89. PubMed ID: 27190008
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal patterns of β-amyloid deposition in nondemented older adults.
Sojkova J; Zhou Y; An Y; Kraut MA; Ferrucci L; Wong DF; Resnick SM
Arch Neurol; 2011 May; 68(5):644-9. PubMed ID: 21555640
[TBL] [Abstract][Full Text] [Related]
5. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
[TBL] [Abstract][Full Text] [Related]
6. Amyloid imaging with carbon 11-labeled Pittsburgh compound B for traumatic brain injury.
Hong YT; Veenith T; Dewar D; Outtrim JG; Mani V; Williams C; Pimlott S; Hutchinson PJ; Tavares A; Canales R; Mathis CA; Klunk WE; Aigbirhio FI; Coles JP; Baron JC; Pickard JD; Fryer TD; Stewart W; Menon DK
JAMA Neurol; 2014 Jan; 71(1):23-31. PubMed ID: 24217171
[TBL] [Abstract][Full Text] [Related]
7. Using positron emission tomography and Carbon 11-labeled Pittsburgh Compound B to image Brain Fibrillar β-amyloid in adults with down syndrome: safety, acceptability, and feasibility.
Landt J; D'Abrera JC; Holland AJ; Aigbirhio FI; Fryer TD; Canales R; Hong YT; Menon DK; Baron JC; Zaman SH
Arch Neurol; 2011 Jul; 68(7):890-6. PubMed ID: 21403005
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome.
Lao PJ; Handen BL; Betthauser TJ; Mihaila I; Hartley SL; Cohen AD; Tudorascu DL; Bulova PD; Lopresti BJ; Tumuluru RV; Murali D; Mathis CA; Barnhart TE; Stone CK; Price JC; Devenny DA; Johnson SC; Klunk WE; Christian BT
J Alzheimers Dis; 2018; 61(2):631-644. PubMed ID: 29254096
[TBL] [Abstract][Full Text] [Related]
9. Imaging beta-amyloid burden in aging and dementia.
Rowe CC; Ng S; Ackermann U; Gong SJ; Pike K; Savage G; Cowie TF; Dickinson KL; Maruff P; Darby D; Smith C; Woodward M; Merory J; Tochon-Danguy H; O'Keefe G; Klunk WE; Mathis CA; Price JC; Masters CL; Villemagne VL
Neurology; 2007 May; 68(20):1718-25. PubMed ID: 17502554
[TBL] [Abstract][Full Text] [Related]
10. Cognitive functioning in relation to brain amyloid-β in healthy adults with Down syndrome.
Hartley SL; Handen BL; Devenny DA; Hardison R; Mihaila I; Price JC; Cohen AD; Klunk WE; Mailick MR; Johnson SC; Christian BT
Brain; 2014 Sep; 137(Pt 9):2556-63. PubMed ID: 24993958
[TBL] [Abstract][Full Text] [Related]
11. Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan.
LeVine H; Spielmann HP; Matveev S; Cauvi FM; Murphy MP; Beckett TL; McCarty K; Lott IT; Doran E; Schmitt F; Head E
Neurobiol Aging; 2017 Jun; 54():163-169. PubMed ID: 28385551
[TBL] [Abstract][Full Text] [Related]
12. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
[TBL] [Abstract][Full Text] [Related]
13. Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
Villeneuve S; Rabinovici GD; Cohn-Sheehy BI; Madison C; Ayakta N; Ghosh PM; La Joie R; Arthur-Bentil SK; Vogel JW; Marks SM; Lehmann M; Rosen HJ; Reed B; Olichney J; Boxer AL; Miller BL; Borys E; Jin LW; Huang EJ; Grinberg LT; DeCarli C; Seeley WW; Jagust W
Brain; 2015 Jul; 138(Pt 7):2020-33. PubMed ID: 25953778
[TBL] [Abstract][Full Text] [Related]
14. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
[TBL] [Abstract][Full Text] [Related]
15. Cognitive decline and brain amyloid-β accumulation across 3 years in adults with Down syndrome.
Hartley SL; Handen BL; Devenny D; Mihaila I; Hardison R; Lao PJ; Klunk WE; Bulova P; Johnson SC; Christian BT
Neurobiol Aging; 2017 Oct; 58():68-76. PubMed ID: 28715661
[TBL] [Abstract][Full Text] [Related]
16. Comparison of longitudinal Aβ in nondemented elderly and Down syndrome.
Tudorascu DL; Anderson SJ; Minhas DS; Yu Z; Comer D; Lao P; Hartley S; Laymon CM; Snitz BE; Lopresti BJ; Johnson S; Price JC; Mathis CA; Aizenstein HJ; Klunk WE; Handen BL; Christian BT; Cohen AD
Neurobiol Aging; 2019 Jan; 73():171-176. PubMed ID: 30359879
[TBL] [Abstract][Full Text] [Related]
17. Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.
Okamura N; Furumoto S; Fodero-Tavoletti MT; Mulligan RS; Harada R; Yates P; Pejoska S; Kudo Y; Masters CL; Yanai K; Rowe CC; Villemagne VL
Brain; 2014 Jun; 137(Pt 6):1762-71. PubMed ID: 24681664
[TBL] [Abstract][Full Text] [Related]
18. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
Grimmer T; Riemenschneider M; Förstl H; Henriksen G; Klunk WE; Mathis CA; Shiga T; Wester HJ; Kurz A; Drzezga A
Biol Psychiatry; 2009 Jun; 65(11):927-34. PubMed ID: 19268916
[TBL] [Abstract][Full Text] [Related]
19. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
[TBL] [Abstract][Full Text] [Related]
20. Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.
Cohen AD; McDade E; Christian B; Price J; Mathis C; Klunk W; Handen BL
Alzheimers Dement; 2018 Jun; 14(6):743-750. PubMed ID: 29477284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
